Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2025)

Camp4 Therapeutics' Enterprise Value history spans 3 years, with the latest figure at -$110.9 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 73.12% year-over-year to -$110.9 million; the TTM value through Dec 2025 reached -$110.9 million, down 73.12%, while the annual FY2025 figure was -$110.9 million, 73.12% down from the prior year.
  • Enterprise Value for Q4 2025 was -$110.9 million at Camp4 Therapeutics, down from -$75.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$2.5 million in Q3 2024 and bottomed at -$110.9 million in Q4 2025.
  • The 3-year median for Enterprise Value is -$49.9 million (2023), against an average of -$53.7 million.
  • The largest annual shift saw Enterprise Value skyrocketed 94.99% in 2024 before it crashed 2878.64% in 2025.
  • A 3-year view of Enterprise Value shows it stood at -$38.4 million in 2023, then crashed by 66.86% to -$64.0 million in 2024, then plummeted by 73.12% to -$110.9 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Enterprise Value are -$110.9 million (Q4 2025), -$75.3 million (Q3 2025), and -$39.1 million (Q2 2025).